Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Fortress Biotech, Inc.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
27.2% vs price
Base Case (Median)
99.2% vs price
Bull Case (75th pct.)
171.1% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| PE Comparable | $60.59 | 243.1% | Medium (25%) |
| Graham Number | $9.76 | -44.7% | Medium (40%) |
Based on 2 out of 7 methods, FBIOP appears undervalued at the current price of $17.66. The base case fair value of $35.18 implies 99.2% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.